Literature DB >> 20111667

Velo-Cardio-Facial Syndrome.

Doron Gothelf1, Amos Frisch, Elena Michaelovsky, Abraham Weizman, Robert J Shprintzen.   

Abstract

Velocardiofacial syndrome (VCFS) also known as DiGeorge, conotruncal anomaly face and Cayler syndromes is caused by a microdeletion in the long arm of chromosome 22. We review the history of the syndrome from the first clinical reports almost half a century ago to the current intriguing molecular findings associating genes from the microdeletion region and the physical and neuropsychiatric phenotype of the syndrome. Velocardiofacial syndrome has a wide spectrum of more than 200 physical manifestations including palate and cardiac anomalies. Yet, the most challenging manifestations of VCFS are the learning disabilities and neuropsychiatric disorders. As VCFS is relatively common and as up to one third of the subjects with VCFS develop schizophrenia like psychotic disorder the syndrome is the most commonly known genetic risk factor to schizophrenia. Identifying the genetic, cognitive and psychiatric risk factors for VCFS-schizophrenia is under the focus of intensive research.

Entities:  

Year:  2009        PMID: 20111667      PMCID: PMC2811959          DOI: 10.1080/19315860902756136

Source DB:  PubMed          Journal:  J Ment Health Res Intellect Disabil        ISSN: 1931-5872


  95 in total

1.  [Insufficiency of palatolaryngeal passage as a developmental disorder].

Authors:  E SEDLACKOVA
Journal:  Cas Lek Cesk       Date:  1955-11-25

2.  Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis.

Authors:  W R Kates; C P Burnette; E W Jabs; J Rutberg; A M Murphy; M Grados; M Geraghty; W E Kaufmann; G D Pearlson
Journal:  Biol Psychiatry       Date:  2001-04-15       Impact factor: 13.382

3.  Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study.

Authors:  Linda E Campbell; Eileen Daly; Fiona Toal; Angela Stevens; Rayna Azuma; Marco Catani; Virginia Ng; Therese van Amelsvoort; Xavier Chitnis; William Cutter; Declan G M Murphy; Kieran C Murphy
Journal:  Brain       Date:  2006-03-28       Impact factor: 13.501

4.  Hyperprolinemia is a risk factor for schizoaffective disorder.

Authors:  H Jacquet; C Demily; E Houy; B Hecketsweiler; J Bou; G Raux; J Lerond; G Allio; S Haouzir; A Tillaux; C Bellegou; G Fouldrin; P Delamillieure; J F Ménard; S Dollfus; T D'Amato; M Petit; F Thibaut; T Frébourg; D Campion
Journal:  Mol Psychiatry       Date:  2005-05       Impact factor: 15.992

5.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

Review 6.  22q11 DS: genomic mechanisms and gene function in DiGeorge/velocardiofacial syndrome.

Authors:  Thomas M Maynard; Gloria T Haskell; Jeffrey A Lieberman; Anthony-Samuel LaMantia
Journal:  Int J Dev Neurosci       Date:  2002 Jun-Aug       Impact factor: 2.457

7.  A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R B Goldberg; M L Lewin; E J Sidoti; M D Berkman; R V Argamaso; D Young
Journal:  Cleft Palate J       Date:  1978-01

8.  Strong association of de novo copy number mutations with autism.

Authors:  Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

9.  Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects.

Authors:  Heather F Russell; Deeann Wallis; Michèle M M Mazzocco; Thomas Moshang; Elaine Zackai; Andrew R Zinn; Judith L Ross; Maximilian Muenke
Journal:  J Pediatr Psychol       Date:  2006-03-08

10.  A comprehensive analysis of 22q11 gene expression in the developing and adult brain.

Authors:  T M Maynard; G T Haskell; A Z Peters; L Sikich; J A Lieberman; A-S LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

View more
  15 in total

Review 1.  Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.

Authors:  Kerri L Tang; Kevin M Antshel; Wanda P Fremont; Wendy R Kates
Journal:  J Dev Behav Pediatr       Date:  2015-10       Impact factor: 2.225

2.  A Rare Case of Mosaic Unbalanced Non-Robertsonian Translocation Involving Chromosomes 15 and 22 with Congenital Abnormalities in Monozygotic Twins.

Authors:  Emine I Atli; Engin Atli; Sinem Yalcintepe; Hakan Gurkan
Journal:  Mol Syndromol       Date:  2019-12-21

Review 3.  Developmental trajectories in 22q11.2 deletion.

Authors:  Ann Swillen; Donna McDonald-McGinn
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-05-18       Impact factor: 3.908

4.  Co-existence of other copy number variations with 22q11.2 deletion or duplication: a modifier for variable phenotypes of the syndrome?

Authors:  Deling Li; Mustafa Tekin; Maria Buch; Yao-Shan Fan
Journal:  Mol Cytogenet       Date:  2012-04-09       Impact factor: 2.009

5.  Axis I psychiatric diagnoses in adolescents and young adults with 22q11 deletion syndrome.

Authors:  O Y Ousley; E Smearman; S Fernandez-Carriba; K A Rockers; K Coleman; E F Walker; J F Cubells
Journal:  Eur Psychiatry       Date:  2013-08-02       Impact factor: 5.361

6.  Genes and biological processes commonly disrupted in rare and heterogeneous developmental delay syndromes.

Authors:  Tamim H Shaikh; Chad Haldeman-Englert; Elizabeth A Geiger; Chris P Ponting; Caleb Webber
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

7.  Prenatal sonographic and cytogenetic/molecular findings of 22q11.2 microdeletion syndrome in 48 confirmed cases in a single tertiary center.

Authors:  Tugba Sarac Sivrikoz; Seher Basaran; Recep Has; Birsen Karaman; Ibrahim Halil Kalelioglu; Melike Kirgiz; Umut Altunoglu; Atil Yuksel
Journal:  Arch Gynecol Obstet       Date:  2021-06-18       Impact factor: 2.344

8.  The clinical application of array CGH for the detection of chromosomal defects in 20,126 unselected newborns.

Authors:  Sang-Jin Park; Eun Hye Jung; Ran-Suk Ryu; Hyun Woong Kang; He Doo Chung; Ho-Young Kang
Journal:  Mol Cytogenet       Date:  2013-06-01       Impact factor: 2.009

9.  Characteristic face: a key indicator for direct diagnosis of 22q11.2 deletions in Chinese velocardiofacial syndrome patients.

Authors:  Dandan Wu; Yang Chen; Chen Xu; Ke Wang; Huijun Wang; Fengyun Zheng; Duan Ma; Guomin Wang
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

10.  Genotype-phenotype correlation in 22q11.2 deletion syndrome.

Authors:  Elena Michaelovsky; Amos Frisch; Miri Carmel; Miriam Patya; Omer Zarchi; Tamar Green; Lina Basel-Vanagaite; Abraham Weizman; Doron Gothelf
Journal:  BMC Med Genet       Date:  2012-12-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.